Celularity Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +2,110,617.6% | -17.4% | -3.9% | -3.2% | -64.1% | -7.8% | -19.1% | |
| – | +148,869.9% | +96.1% | -48.4% | -10.0% | -40.9% | +3.9% | -40.1% | |
| – | +113,746.3% | +93.1% | -31.4% | -62.5% | -98.4% | +225.1% | +736.7% | |
| – | +113,746.3% | +93.1% | -31.4% | -62.5% | – | – | +736.7% | |
| – | -21.5% | +112.8% | -20.1% | +33.1% | +44.2% | +34.9% | -65.7% | |
| – | -8.6% | +19.1% | +148.0% | -44.4% | +8.4% | -6.0% | -89.4% | |
| – | +1,555.1% | +35.7% | +0.6% | – | – | – | – | |
| – | -2.7% | -3.0% | +0.0% | -2.9% | -93.9% | +0.0% | +0.0% | |
| – | -31.0% | -53.8% | -1.7% | -1.8% | -90.9% | -15.9% | -16.1% | |
| – | +254,712.5% | +7.5% | -23.7% | -35.8% | -49.1% | +20.3% | +17.4% | |
| – | +13,606.0% | +29.3% | -1.7% | +136.8% | +8.4% | -20.2% | +50.4% | |
| – | – | – | +1.4% | +1,132.5% | – | – | +120.1% | |
| – | -99.6% | +28,444.2% | +72.9% | -37.6% | +143.4% | +64.7% | +13.4% | |
| – | – | – | – | – | – | – | – | |
| – | – | -86.4% | +431.3% | +100.1% | -79.4% | -78.4% | -530.7% | |
| – | – | – | – | – | – | – | – | |
| – | -33.6% | -22.8% | +591.0% | +17.7% | +29.3% | +13.0% | +16.9% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.